evidence: COVID Vaccination Studies: From Double-Blind to Hardly-Blind? [...] As expanded upon in another response [COVS5], we see an inadvertent placebo proneness due to the study design common to huge placebo-controlled vaccine studies (many thousands of subjects) whereby only a fraction of subjects (+/ 170) get diagnosed. The mechanism is a kind of unwanted (inadvertent) distillation process. This inadvertently distilled placebo proneness may interact with even a small blindness breach towards an unknown degree of overvaluation of vaccines' efficacies. [...] Bibliography [COVS1] FDA Briefing Document - Pfizer-BioNTech COVID-19 Vaccine https://www.fda.gov/media/144245/download [COVS2] FDA Briefing Document - Moderna COVID-19 Vaccine https://www.fda.gov/media/144434/download [COVS3] John Strone "Is it possible to conduct a double-blind placebo vaccine study in humans?", 28 December, https://www.bmj.com/content/371/bmj.m4924/rr-3 [COVS4] Peter Doshi, "Pfizer and Moderna’s "95% effective" vaccines—let’s be cautious and first see the full data", November 26, 2020, https://blogs.bmj.com/bmj/2020/11/26/peter-doshi-pfizer-and-modernas-95-...